About the Role
Oxford Nanopore Technologies is seeking an experienced, commercially driven Account Executive based in Brazil to accelerate adoption of our next-generation sequencing technologies, including GridION and PromethION, across academic, government, biotechnology, and pharmaceutical markets in Latin America.
The ideal candidate will have a proven track record in sequencing technology sales and channel distribution management, with demonstrated success driving revenue through distributor and channel partner networks.
Working closely with regional channel partners and internal commercial and technical teams, you will develop new business, expand existing accounts, strengthen partner capabilities, and execute territory strategies that deliver sustainable revenue growth.
What You'll Bring
- Bachelor's degree in Life Sciences or a related scientific discipline preferred.
- Minimum 5 years of field-based commercial experience within the life sciences industry.
- Demonstrated commercial experience selling DNA/RNA sequencing technologies, including next-generation sequencing (NGS) platforms, instruments, or related solutions.
- Proven experience managing and developing distributor/channel partner networks, including joint business planning, partner enablement, pipeline development, and revenue growth.
- Strong understanding of sequencing workflows, applications, and customer requirements within academic, government, biotechnology, and pharmaceutical research environments.
- Proven ability to develop territories, identify new business opportunities, and close complex, multi-stakeholder sales opportunities through channel partners.
- Strong forecasting, pipeline management, strategic account planning, and negotiation capabilities.
- Excellent communication, presentation, and relationship-management skills, with the ability to influence both channel partners and end customers.
- Ability to work independently within a matrixed, international commercial organization.
- Proficiency with CRM systems and structured sales processes.
- Fluency in English, Spanish, and Portuguese.
Nice to Have
- Direct commercial experience with Oxford Nanopore, Illumina, PacBio, or other sequencing technology providers.
- Established relationships with sequencing distributors, research institutions, and genomics customers across Brazil and Latin America.
- Experience introducing emerging sequencing technologies or expanding market adoption within established NGS markets.
- Experience working alongside Field Applications Scientists and technical specialists to support complex sales opportunities.
Oxford Nanopore Technologies is proud to be an equal opportunity employer. We select and employ candidates based on their merits, qualifications, and ability to perform the responsibilities of the role, without regard to gender, marital status, race, religion, color, age, disability, sexual orientation, military status, or veteran status.
This position is based in Brazil and supports Oxford Nanopore Technologies' commercial operations in the region. As Oxford Nanopore Technologies does not currently maintain a legal employing entity in Brazil, the successful candidate will be employed through an authorized third-party employment partner in accordance with applicable Brazilian employment laws.
If you require an accommodation during the application or interview process, please contact [email protected].
#LI-Remote #LI-SH
Oxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments. With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.
Skills Required
- Bachelor's degree in Life Sciences or a related scientific discipline
- At least 5 years of field-based commercial experience in the life sciences industry
- Commercial experience selling DNA/RNA sequencing technologies, NGS platforms, instruments, or related solutions
- Experience managing and developing distributor or channel partner networks
- Understanding of sequencing workflows, applications, and customer requirements in research environments
- Experience developing territories, identifying new business, and closing complex multi-stakeholder sales
- Forecasting, pipeline management, strategic account planning, and negotiation capabilities
- Excellent communication, presentation, and relationship-management skills
- Ability to work independently in a matrixed international commercial organization
- Proficiency with CRM systems and structured sales processes
- Fluency in English, Spanish, and Portuguese
- Commercial experience with Oxford Nanopore, Illumina, PacBio, or other sequencing technology providers
- Established relationships with sequencing distributors, research institutions, and genomics customers across Brazil and Latin America
- Experience introducing emerging sequencing technologies or expanding adoption in established NGS markets
- Experience working with Field Applications Scientists and technical specialists
Oxford Nanopore Technologies Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Oxford Nanopore Technologies and has not been reviewed or approved by Oxford Nanopore Technologies.
-
Fair & Transparent Compensation — Pay is considered good to above average across many roles, with employer-provided ranges visible for several U.S. commercial and applications positions and company materials emphasizing market‑competitive base pay. Commercial and some senior technical posts, particularly in the U.S., are positioned as competitive and often paired with strong variable components.
-
Equity Value & Accessibility — All‑employee share plans in the UK and a U.S. employee stock purchase plan indicate broad access to equity as part of total reward. Company communications highlight attractive bonus and share plans that add meaningful upside beyond base pay.
-
Healthcare Strength — U.S. roles indicate strong health insurance and core protections, while official materials and country overviews reference private medical coverage and wellbeing support. These elements position the health package as a notable strength alongside cash compensation.
Oxford Nanopore Technologies Insights
What We Do
Our goal is to enable the analysis of anything, anywhere, by anyone. We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data. We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society. Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide. Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.
